92 related articles for article (PubMed ID: 3509523)
1. Anthracycline cardiotoxicity in the rat: relationship between ECG changes and morphologic effects induced by different analogues.
Villani F; Favalli L; Lanza E; Rozza-Dionigi A; Poggi P
Chemioterapia; 1987 Jun; 6(2 Suppl):688-90. PubMed ID: 3509523
[No Abstract] [Full Text] [Related]
2. Trifluoperazine does not affect doxorubicin cardiotoxicity in the rat.
Villani F; Monti E; Piccinini F; Favalli L; Rozza Dionigi A; Lanza E; Poggi P
Anticancer Res; 1988; 8(4):659-63. PubMed ID: 3178155
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cardiotoxicity of pirarubicin, epirubicin and doxorubicin in the rat.
Hirano S; Wakazono K; Agata N; Iguchi H; Tone H
Drugs Exp Clin Res; 1994; 20(4):153-60. PubMed ID: 7813387
[TBL] [Abstract][Full Text] [Related]
4. In vitro modeling of the structure-activity determinants of anthracycline cardiotoxicity.
Menna P; Minotti G; Salvatorelli E
Cell Biol Toxicol; 2007 Jan; 23(1):49-62. PubMed ID: 17031515
[TBL] [Abstract][Full Text] [Related]
5. Effects of S-adenosylmethionine (SAMe) on doxorubicin-induced cardiotoxicity in the rat.
Russo S; Filippelli W; Ferraraccio F; Berrino L; Guarino V; Rossi F
J Med; 1994; 25(1-2):65-89. PubMed ID: 7930959
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of anthracycline cardiotoxicity with the model of isolated, perfused rat heart: comparison of new analogues versus doxorubicin.
Pouna P; Bonoron-Adèle S; Gouverneur G; Tariosse L; Besse P; Robert J
Cancer Chemother Pharmacol; 1995; 35(3):257-61. PubMed ID: 7805186
[TBL] [Abstract][Full Text] [Related]
7. Electrocardiographic and transmembrane potential effects of 5-iminodaunorubicin in the rat.
Jensen RA; Acton EM; Peters JH
Cancer Res; 1984 Sep; 44(9):4030-9. PubMed ID: 6744318
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin cardiotoxicity in the rat: comparison of electrocardiogram, transmembrane potential, and structural effects.
Jensen RA; Acton EM; Peters JH
J Cardiovasc Pharmacol; 1984; 6(1):186-200. PubMed ID: 6199603
[TBL] [Abstract][Full Text] [Related]
9. The rat model in the comparative evaluation of anthracyclines cardiotoxicity.
Lanza E; Rozza A; Favalli L; Monti E; Poggi P; Villani F
Tumori; 1989 Dec; 75(6):533-6. PubMed ID: 2617699
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cardiac guanylate cyclase by doxorubicin and some of its analogs.
Lehotay DC; Levey BA; Levey GS
Biomed Pharmacother; 1983; 37(7):312-6. PubMed ID: 6141818
[TBL] [Abstract][Full Text] [Related]
11. Preliminary echocardiographic and polygraphic evaluation of cardiac toxicity of 4'-epi-doxorubicin.
Villani F; Comazzi R; Lacaita G; Genitoni V; Guindani A; Martini A
Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):203-8. PubMed ID: 6574995
[TBL] [Abstract][Full Text] [Related]
12. Preclinical assessment of anthracycline cardiotoxicity in laboratory animals: predictiveness and pitfalls.
Robert J
Cell Biol Toxicol; 2007 Jan; 23(1):27-37. PubMed ID: 17041747
[TBL] [Abstract][Full Text] [Related]
13. [Contribution of electron microscopy to the study of anthracycline cardiotoxicity].
Anjo A; Levi F; Reynes M
Bull Assoc Anat (Nancy); 1991 Jun; 75(229):7-9. PubMed ID: 1777720
[No Abstract] [Full Text] [Related]
14. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
[TBL] [Abstract][Full Text] [Related]
15. General and cardiac toxicity of adriamycinol in rats.
Danesi R; Del Tacca M; Della Torre P; Bernardini C
Anticancer Res; 1986; 6(5):967-72. PubMed ID: 3800337
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cardiotoxicity of a new anthracycline derivative: 4'-deoxy-4'-iodo-doxorubicin.
Villani F; Galimberti M; Lanza E; Rozza A; Favalli L; Poggi P
Invest New Drugs; 1988 Sep; 6(3):173-8. PubMed ID: 3192383
[TBL] [Abstract][Full Text] [Related]
17. Effect of lycopene on doxorubicin-induced cardiotoxicity: an echocardiographic, histological and morphometrical assessment.
Anjos Ferreira AL; Russell RM; Rocha N; Placido Ladeira MS; Favero Salvadori DM; Oliveira Nascimento MC; Matsui M; Carvalho FA; Tang G; Matsubara LS; Matsubara BB
Basic Clin Pharmacol Toxicol; 2007 Jul; 101(1):16-24. PubMed ID: 17577311
[TBL] [Abstract][Full Text] [Related]
18. [Experimental cardiotoxicity of adriamycin].
Bertazzoli C; Solcia E; Sala L; Dell'oro I; Rovero C; Caccia G
G Ital Chemioter; 1975; 22(1-2):19-26. PubMed ID: 1235347
[No Abstract] [Full Text] [Related]
19. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
Saad SY; Najjar TA; Alashari M
J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
[TBL] [Abstract][Full Text] [Related]
20. Morphine is protective against doxorubicin-induced cardiotoxicity in rat.
Kelishomi RB; Ejtemaeemehr S; Tavangar SM; Rahimian R; Mobarakeh JI; Dehpour AR
Toxicology; 2008 Jan; 243(1-2):96-104. PubMed ID: 17988779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
